JournalsHub
.online
Find My Journal
BJ

Bruce E. Johnson

Harvard University US

ORCID iD 0000-0002-5252-3677
1,087
Publications
87,159
Citations
122
H-Index
382
i10-Index
1.59
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee, Sean Tracy, Heidi Greulich +12 more
Science 2004
9,384
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling OA
Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, Youngchul Song, Courtney Hyland +14 more
Science 2007
4,447
<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib OA
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, Pasi A. Jänne, Olivier Kocher +5 more
New England Journal of Medicine 2005
3,922
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
Alexander Kamb, Nelleke A. Gruis, Jane Weaver-Feldhaus, Qingyun Liu, Keith Harshman +5 more
Science 1994
2,790
Somatic mutations affect key pathways in lung adenocarcinoma OA
Li Ding, Gad Getz, David A. Wheeler, Elaine R. Mardis, Michael D. McLellan +85 more
Nature 2008
2,733

Publications

1,082 total

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade PDF

Livnat Jerby‐Arnon, Parin Shah, Michael S. Cuoco, Christopher Rodman, Mei-Ju Su et al. - Cell, 2018
Cited by 1,418 OpenAlex

Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial PDF

David Planchard, Egbert F. Smit, Harry J.M. Groen, Julien Mazières, Benjamin Besse et al. - The Lancet Oncology, 2017
Cited by 1,354 OpenAlex

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints PDF

Shohei Koyama, Esra A. Akbay, Yvonne Y. Li, Grit S. Herter-Sprie, Kevin A. Buczkowski et al. - Nature Communications, 2016
Cited by 1,550 OpenAlex

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets PDF

Priscilla K. Brastianos, Scott L. Carter, Sandro Santagata, Daniel P. Cahill, Amaro Taylor‐Weiner et al. - Cancer Discovery, 2015
Cited by 1,122 OpenAlex

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate et al. - JAMA, 2014
Cited by 1,728 OpenAlex

Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing PDF

Marcin Imieliński, Alice H. Berger, Peter S. Hammerman, Bryan Hernandez, Trevor J. Pugh et al. - Cell, 2012
Cited by 1,821 OpenAlex

Somatic mutations affect key pathways in lung adenocarcinoma PDF

Li Ding, Gad Getz, David A. Wheeler, Elaine R. Mardis, Michael D. McLellan et al. - Nature, 2008
Cited by 2,733 OpenAlex

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling PDF

Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, Youngchul Song, Courtney Hyland et al. - Science, 2007
Cited by 4,447 OpenAlex

<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib PDF

Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, Pasi A. Jänne, Olivier Kocher et al. - New England Journal of Medicine, 2005
Cited by 3,922 OpenAlex

TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer PDF

Roy S. Herbst, Diane Prager, Róbert Hermann, L. Fehrenbacher, Bruce E. Johnson et al. - Journal of Clinical Oncology, 2005
Cited by 1,497 OpenAlex

Research Topics

Lung Cancer Treatments and Mutations (461) Cancer Genomics and Diagnostics (183) Lung Cancer Research Studies (178) Immunotherapy and Immune Responses (135) Cancer Immunotherapy and Biomarkers (118)

Frequent Co-Authors

PA
Pasi A. Jänne
6 joint publications
MA
Matthew Meyerson
6 joint publications
ST
Stacey Gabriel
4 joint publications
ER
Eric S. Lander
4 joint publications
HE
Heidi Greulich
3 joint publications
GA
Gad Getz
3 joint publications

Affiliations

The Wistar Institute
US 2019 - 2019
AstraZeneca (United Kingdom)
GB 2009 - 2005
Broad Institute
US 2020 - 2013
Boston University
US 2013 - 2013
Northwestern University
US 2005 - 2005

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now